follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Pacira Pharmaceuticals announces proposed public offering of stock

By

Back to Top Comments Email Print

Latest News

advertisement

Parsippany-based Pacira Pharmaceuticals Inc. announced Tuesday that it is offering $100 million of its common stock in a proposed public offering.

According to the release, Pacira plans to grant underwriters 30 days to purchase up to $15 million of additional shares.

Jeffries LLC, Barclays Capital Inc. and BofA Merrill Lynch are acting as the joint bookrunning managers and underwriters for the offering.

ALSO ON NJBIZ:

Green developer Jonathan F. P. Rose preaches sustainability with South Orange site

NJBIZ names the 2014 General Counsel of the Year finalists

Small business owners: Stronger NJ grant process not working

Share This Story On:
Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top